|
MK-3120 Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: SKB410
Birmingham, Alabama1 trial
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
The University of Alabama at Birmingham ( Site 1005)
Phase 1/2
Bakersfield, California1 trial
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Michael G Oefelein Clinical Trials ( Site 0005)
Phase 1/2
Salt Lake City, Utah1 trial
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Huntsman Cancer Institute ( Site 5041)
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.